Injectable Viscosupplementation for Joint Market, Global Outlook and Forecast 2022-2028
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report contains market size and forecasts of Injectable Viscosupplementation for Joint in global, including the following market information:
Global Injectable Viscosupplementation for Joint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Viscosupplementation for Joint Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Injectable Viscosupplementation for Joint companies in 2021 (%)
The global Injectable Viscosupplementation for Joint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Viscosupplementation for Joint include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Viscosupplementation for Joint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Viscosupplementation for Joint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Type, 2021 (%)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Application, 2021 (%)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Injectable Viscosupplementation for Joint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Viscosupplementation for Joint revenues share in global market, 2021 (%)
Key companies Injectable Viscosupplementation for Joint sales in global market, 2017-2022 (Estimated), (Units)
Key companies Injectable Viscosupplementation for Joint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Injectable Viscosupplementation for Joint in global, including the following market information:
Global Injectable Viscosupplementation for Joint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Viscosupplementation for Joint Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Injectable Viscosupplementation for Joint companies in 2021 (%)
The global Injectable Viscosupplementation for Joint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Viscosupplementation for Joint include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Viscosupplementation for Joint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Viscosupplementation for Joint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Type, 2021 (%)
- Single Injection
- Three Injection
- Five Injection
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Other
Global Injectable Viscosupplementation for Joint Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Injectable Viscosupplementation for Joint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Viscosupplementation for Joint revenues share in global market, 2021 (%)
Key companies Injectable Viscosupplementation for Joint sales in global market, 2017-2022 (Estimated), (Units)
Key companies Injectable Viscosupplementation for Joint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- Anika Therapeutics
- Seikagaku
- Zimmer Biomet
- Bioventus
- Ferring
- LG Chem
- Freda
- Haohai Biological
- Shanghai Jingfeng
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Injectable Viscosupplementation for Joint Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Viscosupplementation for Joint Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT OVERALL MARKET SIZE
2.1 Global Injectable Viscosupplementation for Joint Market Size: 2021 VS 2028
2.2 Global Injectable Viscosupplementation for Joint Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Injectable Viscosupplementation for Joint Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Injectable Viscosupplementation for Joint Players in Global Market
3.2 Top Global Injectable Viscosupplementation for Joint Companies Ranked by Revenue
3.3 Global Injectable Viscosupplementation for Joint Revenue by Companies
3.4 Global Injectable Viscosupplementation for Joint Sales by Companies
3.5 Global Injectable Viscosupplementation for Joint Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Injectable Viscosupplementation for Joint Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Injectable Viscosupplementation for Joint Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Players in Global Market
3.8.1 List of Global Tier 1 Injectable Viscosupplementation for Joint Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Injectable Viscosupplementation for Joint Market Size Markets, 2021 & 2028
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
4.2.1 By Type - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
4.2.2 By Type - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
4.2.3 By Type - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
4.3 By Type - Global Injectable Viscosupplementation for Joint Sales & Forecasts
4.3.1 By Type - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
4.3.2 By Type - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
4.3.3 By Type - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
4.4 By Type - Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
5.2.1 By Application - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
5.2.2 By Application - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
5.2.3 By Application - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
5.3 By Application - Global Injectable Viscosupplementation for Joint Sales & Forecasts
5.3.1 By Application - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
5.3.2 By Application - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
5.3.3 By Application - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
5.4 By Application - Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
6.2 By Region - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
6.2.1 By Region - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
6.2.2 By Region - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
6.2.3 By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
6.3 By Region - Global Injectable Viscosupplementation for Joint Sales & Forecasts
6.3.1 By Region - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
6.3.2 By Region - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
6.3.3 By Region - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.4.2 By Country - North America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.4.3 US Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.4 Canada Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.5 Mexico Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.5.2 By Country - Europe Injectable Viscosupplementation for Joint Sales, 2017-2028
6.5.3 Germany Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.4 France Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.5 U.K. Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.6 Italy Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.7 Russia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.8 Nordic Countries Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.9 Benelux Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.6.2 By Region - Asia Injectable Viscosupplementation for Joint Sales, 2017-2028
6.6.3 China Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.4 Japan Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.5 South Korea Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.6 Southeast Asia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.7 India Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.7.2 By Country - South America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.7.3 Brazil Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7.4 Argentina Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, 2017-2028
6.8.3 Turkey Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.4 Israel Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.5 Saudi Arabia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.6 UAE Injectable Viscosupplementation for Joint Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injectable Viscosupplementation for Joint Major Product Offerings
7.1.4 Sanofi Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Corporate Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Major Product Offerings
7.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.2.5 Anika Therapeutics Key News
7.3 Seikagaku
7.3.1 Seikagaku Corporate Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Injectable Viscosupplementation for Joint Major Product Offerings
7.3.4 Seikagaku Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.3.5 Seikagaku Key News
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Corporate Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Major Product Offerings
7.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.4.5 Zimmer Biomet Key News
7.5 Bioventus
7.5.1 Bioventus Corporate Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Injectable Viscosupplementation for Joint Major Product Offerings
7.5.4 Bioventus Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.5.5 Bioventus Key News
7.6 Ferring
7.6.1 Ferring Corporate Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Injectable Viscosupplementation for Joint Major Product Offerings
7.6.4 Ferring Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.6.5 Ferring Key News
7.7 LG Chem
7.7.1 LG Chem Corporate Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Injectable Viscosupplementation for Joint Major Product Offerings
7.7.4 LG Chem Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.7.5 LG Chem Key News
7.8 Freda
7.8.1 Freda Corporate Summary
7.8.2 Freda Business Overview
7.8.3 Freda Injectable Viscosupplementation for Joint Major Product Offerings
7.8.4 Freda Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.8.5 Freda Key News
7.9 Haohai Biological
7.9.1 Haohai Biological Corporate Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Injectable Viscosupplementation for Joint Major Product Offerings
7.9.4 Haohai Biological Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.9.5 Haohai Biological Key News
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Corporate Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Major Product Offerings
7.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Jingfeng Key News
8 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Injectable Viscosupplementation for Joint Production Capacity, 2017-2028
8.2 Injectable Viscosupplementation for Joint Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Viscosupplementation for Joint Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INJECTABLE VISCOSUPPLEMENTATION FOR JOINT SUPPLY CHAIN ANALYSIS
10.1 Injectable Viscosupplementation for Joint Industry Value Chain
10.2 Injectable Viscosupplementation for Joint Upstream Market
10.3 Injectable Viscosupplementation for Joint Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Injectable Viscosupplementation for Joint Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Viscosupplementation for Joint Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT OVERALL MARKET SIZE
2.1 Global Injectable Viscosupplementation for Joint Market Size: 2021 VS 2028
2.2 Global Injectable Viscosupplementation for Joint Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Injectable Viscosupplementation for Joint Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Injectable Viscosupplementation for Joint Players in Global Market
3.2 Top Global Injectable Viscosupplementation for Joint Companies Ranked by Revenue
3.3 Global Injectable Viscosupplementation for Joint Revenue by Companies
3.4 Global Injectable Viscosupplementation for Joint Sales by Companies
3.5 Global Injectable Viscosupplementation for Joint Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Injectable Viscosupplementation for Joint Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Injectable Viscosupplementation for Joint Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Players in Global Market
3.8.1 List of Global Tier 1 Injectable Viscosupplementation for Joint Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Injectable Viscosupplementation for Joint Market Size Markets, 2021 & 2028
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
4.2.1 By Type - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
4.2.2 By Type - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
4.2.3 By Type - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
4.3 By Type - Global Injectable Viscosupplementation for Joint Sales & Forecasts
4.3.1 By Type - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
4.3.2 By Type - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
4.3.3 By Type - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
4.4 By Type - Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
5.2.1 By Application - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
5.2.2 By Application - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
5.2.3 By Application - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
5.3 By Application - Global Injectable Viscosupplementation for Joint Sales & Forecasts
5.3.1 By Application - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
5.3.2 By Application - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
5.3.3 By Application - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
5.4 By Application - Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
6.2 By Region - Global Injectable Viscosupplementation for Joint Revenue & Forecasts
6.2.1 By Region - Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
6.2.2 By Region - Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
6.2.3 By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
6.3 By Region - Global Injectable Viscosupplementation for Joint Sales & Forecasts
6.3.1 By Region - Global Injectable Viscosupplementation for Joint Sales, 2017-2022
6.3.2 By Region - Global Injectable Viscosupplementation for Joint Sales, 2023-2028
6.3.3 By Region - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.4.2 By Country - North America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.4.3 US Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.4 Canada Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.5 Mexico Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.5.2 By Country - Europe Injectable Viscosupplementation for Joint Sales, 2017-2028
6.5.3 Germany Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.4 France Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.5 U.K. Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.6 Italy Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.7 Russia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.8 Nordic Countries Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.9 Benelux Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.6.2 By Region - Asia Injectable Viscosupplementation for Joint Sales, 2017-2028
6.6.3 China Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.4 Japan Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.5 South Korea Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.6 Southeast Asia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.7 India Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.7.2 By Country - South America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.7.3 Brazil Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7.4 Argentina Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, 2017-2028
6.8.3 Turkey Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.4 Israel Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.5 Saudi Arabia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.6 UAE Injectable Viscosupplementation for Joint Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injectable Viscosupplementation for Joint Major Product Offerings
7.1.4 Sanofi Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Corporate Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Major Product Offerings
7.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.2.5 Anika Therapeutics Key News
7.3 Seikagaku
7.3.1 Seikagaku Corporate Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Injectable Viscosupplementation for Joint Major Product Offerings
7.3.4 Seikagaku Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.3.5 Seikagaku Key News
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Corporate Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Major Product Offerings
7.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.4.5 Zimmer Biomet Key News
7.5 Bioventus
7.5.1 Bioventus Corporate Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Injectable Viscosupplementation for Joint Major Product Offerings
7.5.4 Bioventus Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.5.5 Bioventus Key News
7.6 Ferring
7.6.1 Ferring Corporate Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Injectable Viscosupplementation for Joint Major Product Offerings
7.6.4 Ferring Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.6.5 Ferring Key News
7.7 LG Chem
7.7.1 LG Chem Corporate Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Injectable Viscosupplementation for Joint Major Product Offerings
7.7.4 LG Chem Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.7.5 LG Chem Key News
7.8 Freda
7.8.1 Freda Corporate Summary
7.8.2 Freda Business Overview
7.8.3 Freda Injectable Viscosupplementation for Joint Major Product Offerings
7.8.4 Freda Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.8.5 Freda Key News
7.9 Haohai Biological
7.9.1 Haohai Biological Corporate Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Injectable Viscosupplementation for Joint Major Product Offerings
7.9.4 Haohai Biological Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.9.5 Haohai Biological Key News
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Corporate Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Major Product Offerings
7.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Jingfeng Key News
8 GLOBAL INJECTABLE VISCOSUPPLEMENTATION FOR JOINT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Injectable Viscosupplementation for Joint Production Capacity, 2017-2028
8.2 Injectable Viscosupplementation for Joint Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Viscosupplementation for Joint Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INJECTABLE VISCOSUPPLEMENTATION FOR JOINT SUPPLY CHAIN ANALYSIS
10.1 Injectable Viscosupplementation for Joint Industry Value Chain
10.2 Injectable Viscosupplementation for Joint Upstream Market
10.3 Injectable Viscosupplementation for Joint Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Injectable Viscosupplementation for Joint in Global Market
Table 2. Top Injectable Viscosupplementation for Joint Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Injectable Viscosupplementation for Joint Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Injectable Viscosupplementation for Joint Revenue Share by Companies, 2017-2022
Table 5. Global Injectable Viscosupplementation for Joint Sales by Companies, (Units), 2017-2022
Table 6. Global Injectable Viscosupplementation for Joint Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Injectable Viscosupplementation for Joint Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Injectable Viscosupplementation for Joint Product Type
Table 9. List of Global Tier 1 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 15. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 16. By Application – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 20. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 21. By Region – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 25. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 26. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 29. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 30. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 33. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 34. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 37. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 38. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 41. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Injectable Viscosupplementation for Joint Product Offerings
Table 48. Sanofi Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Anika Therapeutics Corporate Summary
Table 50. Anika Therapeutics Injectable Viscosupplementation for Joint Product Offerings
Table 51. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Seikagaku Corporate Summary
Table 53. Seikagaku Injectable Viscosupplementation for Joint Product Offerings
Table 54. Seikagaku Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Zimmer Biomet Corporate Summary
Table 56. Zimmer Biomet Injectable Viscosupplementation for Joint Product Offerings
Table 57. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bioventus Corporate Summary
Table 59. Bioventus Injectable Viscosupplementation for Joint Product Offerings
Table 60. Bioventus Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ferring Corporate Summary
Table 62. Ferring Injectable Viscosupplementation for Joint Product Offerings
Table 63. Ferring Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. LG Chem Corporate Summary
Table 65. LG Chem Injectable Viscosupplementation for Joint Product Offerings
Table 66. LG Chem Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Freda Corporate Summary
Table 68. Freda Injectable Viscosupplementation for Joint Product Offerings
Table 69. Freda Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Haohai Biological Corporate Summary
Table 71. Haohai Biological Injectable Viscosupplementation for Joint Product Offerings
Table 72. Haohai Biological Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shanghai Jingfeng Corporate Summary
Table 74. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Offerings
Table 75. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Injectable Viscosupplementation for Joint Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Injectable Viscosupplementation for Joint Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Injectable Viscosupplementation for Joint Production by Region, 2017-2022 (Units)
Table 79. Global Injectable Viscosupplementation for Joint Production by Region, 2023-2028 (Units)
Table 80. Injectable Viscosupplementation for Joint Market Opportunities & Trends in Global Market
Table 81. Injectable Viscosupplementation for Joint Market Drivers in Global Market
Table 82. Injectable Viscosupplementation for Joint Market Restraints in Global Market
Table 83. Injectable Viscosupplementation for Joint Raw Materials
Table 84. Injectable Viscosupplementation for Joint Raw Materials Suppliers in Global Market
Table 85. Typical Injectable Viscosupplementation for Joint Downstream
Table 86. Injectable Viscosupplementation for Joint Downstream Clients in Global Market
Table 87. Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global Market
Table 1. Key Players of Injectable Viscosupplementation for Joint in Global Market
Table 2. Top Injectable Viscosupplementation for Joint Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Injectable Viscosupplementation for Joint Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Injectable Viscosupplementation for Joint Revenue Share by Companies, 2017-2022
Table 5. Global Injectable Viscosupplementation for Joint Sales by Companies, (Units), 2017-2022
Table 6. Global Injectable Viscosupplementation for Joint Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Injectable Viscosupplementation for Joint Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Injectable Viscosupplementation for Joint Product Type
Table 9. List of Global Tier 1 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 15. By Type - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 16. By Application – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 20. By Application - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 21. By Region – Global Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Injectable Viscosupplementation for Joint Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2017-2022
Table 25. By Region - Global Injectable Viscosupplementation for Joint Sales (Units), 2023-2028
Table 26. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 29. By Country - North America Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 30. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 33. By Country - Europe Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 34. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 37. By Region - Asia Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 38. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 41. By Country - South America Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales, (Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Injectable Viscosupplementation for Joint Product Offerings
Table 48. Sanofi Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Anika Therapeutics Corporate Summary
Table 50. Anika Therapeutics Injectable Viscosupplementation for Joint Product Offerings
Table 51. Anika Therapeutics Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Seikagaku Corporate Summary
Table 53. Seikagaku Injectable Viscosupplementation for Joint Product Offerings
Table 54. Seikagaku Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Zimmer Biomet Corporate Summary
Table 56. Zimmer Biomet Injectable Viscosupplementation for Joint Product Offerings
Table 57. Zimmer Biomet Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bioventus Corporate Summary
Table 59. Bioventus Injectable Viscosupplementation for Joint Product Offerings
Table 60. Bioventus Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Ferring Corporate Summary
Table 62. Ferring Injectable Viscosupplementation for Joint Product Offerings
Table 63. Ferring Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. LG Chem Corporate Summary
Table 65. LG Chem Injectable Viscosupplementation for Joint Product Offerings
Table 66. LG Chem Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Freda Corporate Summary
Table 68. Freda Injectable Viscosupplementation for Joint Product Offerings
Table 69. Freda Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Haohai Biological Corporate Summary
Table 71. Haohai Biological Injectable Viscosupplementation for Joint Product Offerings
Table 72. Haohai Biological Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Shanghai Jingfeng Corporate Summary
Table 74. Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Offerings
Table 75. Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Injectable Viscosupplementation for Joint Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Injectable Viscosupplementation for Joint Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Injectable Viscosupplementation for Joint Production by Region, 2017-2022 (Units)
Table 79. Global Injectable Viscosupplementation for Joint Production by Region, 2023-2028 (Units)
Table 80. Injectable Viscosupplementation for Joint Market Opportunities & Trends in Global Market
Table 81. Injectable Viscosupplementation for Joint Market Drivers in Global Market
Table 82. Injectable Viscosupplementation for Joint Market Restraints in Global Market
Table 83. Injectable Viscosupplementation for Joint Raw Materials
Table 84. Injectable Viscosupplementation for Joint Raw Materials Suppliers in Global Market
Table 85. Typical Injectable Viscosupplementation for Joint Downstream
Table 86. Injectable Viscosupplementation for Joint Downstream Clients in Global Market
Table 87. Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Injectable Viscosupplementation for Joint Segment by Type
Figure 2. Injectable Viscosupplementation for Joint Segment by Application
Figure 3. Global Injectable Viscosupplementation for Joint Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Injectable Viscosupplementation for Joint Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Injectable Viscosupplementation for Joint Revenue, 2017-2028 (US$, Mn)
Figure 7. Injectable Viscosupplementation for Joint Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Injectable Viscosupplementation for Joint Revenue in 2021
Figure 9. By Type - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 10. By Type - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 11. By Type - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 13. By Application - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 14. By Application - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 16. By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 17. By Country - North America Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 18. By Country - North America Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 19. US Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 24. Germany Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 25. France Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 33. China Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 37. India Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 39. By Country - South America Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 40. Brazil Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 44. Turkey Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 48. Global Injectable Viscosupplementation for Joint Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Injectable Viscosupplementation for Joint by Region, 2021 VS 2028
Figure 50. Injectable Viscosupplementation for Joint Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Injectable Viscosupplementation for Joint Segment by Type
Figure 2. Injectable Viscosupplementation for Joint Segment by Application
Figure 3. Global Injectable Viscosupplementation for Joint Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Injectable Viscosupplementation for Joint Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Injectable Viscosupplementation for Joint Revenue, 2017-2028 (US$, Mn)
Figure 7. Injectable Viscosupplementation for Joint Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Injectable Viscosupplementation for Joint Revenue in 2021
Figure 9. By Type - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 10. By Type - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 11. By Type - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 13. By Application - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 14. By Application - Global Injectable Viscosupplementation for Joint Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 16. By Region - Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 17. By Country - North America Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 18. By Country - North America Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 19. US Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 24. Germany Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 25. France Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 33. China Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 37. India Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 39. By Country - South America Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 40. Brazil Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
Figure 44. Turkey Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Injectable Viscosupplementation for Joint Revenue, (US$, Mn), 2017-2028
Figure 48. Global Injectable Viscosupplementation for Joint Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Injectable Viscosupplementation for Joint by Region, 2021 VS 2028
Figure 50. Injectable Viscosupplementation for Joint Industry Value Chain
Figure 51. Marketing Channels
